301 related articles for article (PubMed ID: 10478245)
1. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain.
Chan S; Shungu DC; Douglas-Akinwande A; Lange DJ; Rowland LP
Radiology; 1999 Sep; 212(3):763-9. PubMed ID: 10478245
[TBL] [Abstract][Full Text] [Related]
2. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T.
Wang S; Poptani H; Woo JH; Desiderio LM; Elman LB; McCluskey LF; Krejza J; Melhem ER
Radiology; 2006 Jun; 239(3):831-8. PubMed ID: 16641339
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging and magnetic resonance spectroscopy in a patient with amyotrophic lateral sclerosis and frontotemporal dementia.
Sarac H; Zagar M; Vranjes D; Henigsberg N; Bilić E; Pavlisa G
Coll Antropol; 2008 Jan; 32 Suppl 1():205-10. PubMed ID: 18405084
[TBL] [Abstract][Full Text] [Related]
4. Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis.
Lombardo F; Frijia F; Bongioanni P; Canapicchi R; Minichilli F; Bianchi F; Hlavata H; Rossi B; Montanaro D
Arch Ital Biol; 2009 Sep; 147(3):69-82. PubMed ID: 20014653
[TBL] [Abstract][Full Text] [Related]
5. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
[TBL] [Abstract][Full Text] [Related]
6. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.
Liu C; Jiang R; Yi X; Zhu W; Bu B
J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526
[TBL] [Abstract][Full Text] [Related]
7. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
Rooney WD; Miller RG; Gelinas D; Schuff N; Maudsley AA; Weiner MW
Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731
[TBL] [Abstract][Full Text] [Related]
8. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS
Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
[TBL] [Abstract][Full Text] [Related]
9. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
Iwata NK
Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
[TBL] [Abstract][Full Text] [Related]
10. ALS surrogate markers. MRS.
Kalra S; Arnold DL
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():111-4. PubMed ID: 15512889
[TBL] [Abstract][Full Text] [Related]
11. Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis.
Pyra T; Hui B; Hanstock C; Concha L; Wong JC; Beaulieu C; Johnston W; Kalra S
Amyotroph Lateral Scler; 2010; 11(1-2):157-65. PubMed ID: 19242831
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T
Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367
[TBL] [Abstract][Full Text] [Related]
13. The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis.
Cervo A; Cocozza S; Saccà F; Giorgio SMDA; Morra VB; Tedeschi E; Marsili A; Vacca G; Palma V; Brunetti A; Quarantelli M
Eur J Radiol; 2015 Jan; 84(1):151-157. PubMed ID: 25466774
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
Wang S; Melhem ER
Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
[TBL] [Abstract][Full Text] [Related]
15. Structural and metabolic changes in the brain of patients with upper motor neuron disorders: a multiparametric MRI study.
Charil A; Corbo M; Filippi M; Kesavadas C; Agosta F; Munerati E; Gambini A; Comi G; Scotti G; Falini A
Amyotroph Lateral Scler; 2009; 10(5-6):269-79. PubMed ID: 19922113
[TBL] [Abstract][Full Text] [Related]
16. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
[TBL] [Abstract][Full Text] [Related]
17. Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia.
Mascalchi M; Cosottini M; Lolli F; Salvi F; Tessa C; Macucci M; Tosetti M; Plasmati R; Ferlini A; Tassinari CA; Villari N
Radiology; 2002 May; 223(2):371-8. PubMed ID: 11997539
[TBL] [Abstract][Full Text] [Related]
18. Diffusion tensor imaging and quantitative susceptibility mapping as diagnostic tools for motor neuron disorders.
Weidman EK; Schweitzer AD; Niogi SN; Brady EJ; Starikov A; Askin G; Shahbazi M; Wang Y; Lange D; Tsiouris AJ
Clin Imaging; 2019; 53():6-11. PubMed ID: 30286313
[TBL] [Abstract][Full Text] [Related]
19. MR spectroscopy evaluation and short-term outcome of olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients.
Huang H; Tan K; Chen L; Xue Y; Wang H; Xi H; Liu Y; Zhang F; Zhang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jan; 21(1):52-7. PubMed ID: 17305006
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy.
Govind V; Sharma KR; Maudsley AA; Arheart KL; Saigal G; Sheriff S
PLoS One; 2012; 7(4):e35607. PubMed ID: 22539984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
